company will be set up a wholly-owned of the Listed Subsidiary 2. The Construction of Wattanapat Samui Hospital Building Contractor : N/A 3. Buying the Medical Instruments The Company will appropriately

% (20,872) 10.63% (9,226) 44.20% Selling expenses (16,124) 4.41% (4,934) 2.51% (11,190) 226.79% Administrative expenses (78,816) 21.57% (63,952) 32.57% (14,864) 23.24% Share of profit (loss) from investment

purchase of investment in a subsidiary 10,092 1.61% - 0.00% 10,092 0.00% Reversal of allowance for short-term loan and interest receivable 36,761 5.86% - 0.00% 36,761 0.00% Reversal of allowance for

% (8,544) 1.01% 8,544 100.00% Bargain purchase of investment in a subsidiary 10,092 1.01% 2,342 0.28% 7,750 330.91% Gain on sale of investment in subsidiary - 0.00% 137,396 16.21% (137,396) 100.00% Reversal

has a higher inventory and Current Portion of loans receivables from purchases accounts receivables increase. Source of Fund and Capital Structure The Company’s source of fund was divided to share

11.86% Finance cost 19.72 18.41 (1.31) (6.64%) Income tax expenses 17.98 22.21 4.23 23.53% Net profit 70.57 80.50 9.93 14.07% Net profit ratio (ROS) 20.41% 18.98% Earnings per share (Baht) 0.13 0.15 0.02

Discussion and Analysis of the Company’s Performance for the Nine Months Ended 30 September 2018 Total Revenue For the nine-month period ended 30 September 2018, the Company and its subsidiaries earned a total

% Revenue from finance lease under power purchase agreement 102.9 102.8 103.2 0.4% 0.3% 308.4 306.9 (0.5%) Revenue from construction under a concession arrangement 21.2 398.1 215.0 (46.0%) 914.2% 89.7 744.4

purchase agreement 102.8 99.2 101.6 2.4% (1.2%) 203.7 200.8 (1.4%) Revenue from construction under a concession arrangement 398.1 - - - N.A. (

8.59 Cost of sales and Services 1,647.83 1,572.51 4.79 Selling and Administrative Expenses 176.25 171.57 2.73 Share of profit (loss) from investments in (5.30) (3.53) 50.14 joint ventures Finance Cost